Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.

The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2024.

Researcher's newest research report, the “Poliomyelitis Vaccines Industry Forecast” looks at past sales and reviews total world Poliomyelitis Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Poliomyelitis Vaccines sales for 2023 through 2029. With Poliomyelitis Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Poliomyelitis Vaccines industry.

This Insight Report provides a comprehensive analysis of the global Poliomyelitis Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Poliomyelitis Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Poliomyelitis Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Poliomyelitis Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Poliomyelitis Vaccines.

The global Poliomyelitis Vaccines market size is projected to grow from US$ 694.4 million in 2022 to US$ 819 million in 2029; it is expected to grow at a CAGR of 819 from 2023 to 2029.

Sanofi, GSK and Serum Institute are the top 3 players of Polio Vaccine with about 99% market shares.

This report presents a comprehensive overview, market shares, and growth opportunities of Poliomyelitis Vaccines market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

IPV

OPV

Segmentation by application

Research & Academic Laboratories

Pharmaceutical & Biotechnology Companies

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Sanofi

GSK

Bibcol

Serum Institute

Tiantan Biological

IMBCA

Panacea Biotec Ltd

Bio-Med

Halfkin Bio-Pharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Poliomyelitis Vaccines market?

What factors are driving Poliomyelitis Vaccines market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Poliomyelitis Vaccines market opportunities vary by end market size?

How does Poliomyelitis Vaccines break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?